Advanced Oncotherapy PLC (LON:AVO) shares crossed above its 50 day moving average during trading on Friday . The stock has a 50 day moving average of $37.83 and traded as high as $41.00. Advanced Oncotherapy shares last traded at $40.00, with a volume of 177,457 shares trading hands.
The company has a debt-to-equity ratio of 55.71, a current ratio of 2.16 and a quick ratio of 0.79. The stock has a fifty day moving average price of GBX 37.84 and a two-hundred day moving average price of GBX 38.83. The company has a market cap of $97.77 million and a P/E ratio of -2.86.
Advanced Oncotherapy Company Profile (LON:AVO)
Advanced Oncotherapy PLC, together with its subsidiaries, focuses on providing radiotherapy systems for the treatment of cancer. The company operates through two segments, Proton Therapy and Healthcare Related Properties. It is developing Linac Image Guided Hadron Technology, a proton therapy system for treating cancer.
Featured Article: New Google Finance Tool and Screening Stocks
Receive News & Ratings for Advanced Oncotherapy Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Advanced Oncotherapy and related companies with MarketBeat.com's FREE daily email newsletter.